Skip to main content
. Author manuscript; available in PMC: 2017 May 31.
Published in final edited form as: Mol Cancer Res. 2017 Feb 9;15(3):250–258. doi: 10.1158/1541-7786.MCR-16-0132

Figure 1.

Figure 1

CCOC cells are sensitive to sunitinib in vitro. A–C, TOV21G (A), OVTOKO (B), and OVMANA cells (C) were treated with sunitinib for 48 hours under normoxia (21% O2) or hypoxia (1% O2), and cell viability was measured by an MTT assay. Graph, average ± SEM (n = 3).